Barbara Gayle Duncan Insider Profile

4 Followers
Barbara Gayle Duncan, CFO at Intercept Pharma, holds 24.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 9.25K shares in Halozyme (Ticker: HALO). Most recently, Barbara Gayle Duncan Sold ― shares of Intercept Pharma on Oct 05, 2016 for an estimated value of 23.99K.
tipranks
Barbara Gayle Duncan

Barbara Gayle Duncan
Intercept Pharma (ICPT)
CFO

Ranked #4,183 out of 105,137 Corporate Insiders

Profitable Transactions

90%
9 out of 10 Profitable Transactions

Average Return

+40.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$815K
56.63%
43.37%
0.00%
0.00%
0.00% Others
A breakdown of Barbara Gayle Duncan's holdings

Insider Roles

Intercept Pharma
(ICPT)
CFO
Halozyme
(HALO)
Director
Adaptimmune Therapeutics
(ADAP)
Director
Innoviva
(INVA)
Director
+3 other positions
Roles that Barbara Gayle Duncan holds in companies

Most Profitable Insider Trade

Stock:
Immunomedics
(IMMU)
Rating:Informative Buy
Date:Aug 14, 2020 - Aug 14, 2021
Return:+119.60%
The most profitable trade made by Barbara Gayle Duncan

Barbara Gayle Duncan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intercept Pharma
Oct 05, 2016
CFO
Informative Sell
23.99K
$461.50K
Adaptimmune Therapeutics
Director
Innoviva
Apr 24, 2017
Director
Uninformative Buy
$0.00
JNCE
Jounce Therapeutics
Sep 16, 2020
Uninformative Sell
100.00K
$0.00
Ovid Therapeutics
Director
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
Atea Pharmaceuticals
Director
Fusion Pharmaceuticals
Director
Halozyme
May 09, 2023
Director
Uninformative Buy
$353.46K
GNMX
Aevi Genomic Medicine
Oct 18, 2017
Informative Buy
75.00K
$0.00
List of latest transactions for each holding click on a transaction to see Barbara Gayle Duncan's performance on stock

Barbara Gayle Duncan insider profile FAQ

What is the percentage of profitable transactions made by Barbara Gayle Duncan?
The percentage of profitable transactions made by Barbara Gayle Duncan is 90%.
    What is the average return per transaction made by Barbara Gayle Duncan?
    The average return per transaction made by Barbara Gayle Duncan is 40.70%.
      What stocks does Barbara Gayle Duncan hold?
      Barbara Gayle Duncan holds: ICPT, ADAP, INVA, JNCE, OVID, IMMU, AVIR, FUSN, HALO, GNMX stocks.
        What was Barbara Gayle Duncan’s latest transaction?
        Barbara Gayle Duncan latest transaction was an Informative Sell of $23.99K.
          What was Barbara Gayle Duncan's most profitable transaction?
          Barbara Gayle Duncan’s most profitable transaction was an Informative Buy of IMMU stock on August 14, 2020. The return on the trade was 119.60%.
            What is Barbara Gayle Duncan's role in Intercept Pharma?
            Barbara Gayle Duncan's role in Intercept Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.